brokerage reports
Jump to
134 Results Found
  • Weekly Tactical Pick | Aurobindo Pharma Feb 19, 2021 10:44 AM IST

    Weekly Tactical Pick | Aurobindo Pharma

    Valuation at a discount to peers, but significant scope for margin improvement

  • Buy Aurobindo Pharma; target of Rs 1100: Sharekhan Feb 16, 2021 05:24 PM IST

    Buy Aurobindo Pharma; target of Rs 1100: Sharekhan

    Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated February 11, 2021.

  • Buy Aurobindo Pharma; target of Rs 1165: ICICI Direct Feb 15, 2021 06:59 PM IST

    Buy Aurobindo Pharma; target of Rs 1165: ICICI Direct

    ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1165 in its research report dated February 11, 2021.

  • Aurobindo Pharma: Vaccine and API plans inject add-on growth levers Feb 12, 2021 11:06 AM IST

    Aurobindo Pharma: Vaccine and API plans inject add-on growth levers

    In the injectables space, Aurobindo Pharma remains constructive and targets to almost double from current annual sales base of $380 million to $650-700 million in three years backed by new plants in the US and Vizag

  • Gland Pharma Q3: Strong and clean play on global generic injectables; accumulate Jan 25, 2021 09:35 AM IST

    Gland Pharma Q3: Strong and clean play on global generic injectables; accumulate

    We believe dominance of profit/royalty-sharing aspect in the business model distinguishes Gland Pharma from other contract manufacturers

  • Buy Aurobindo Pharma: target of Rs 1024: Sharekhan Dec 18, 2020 01:46 PM IST

    Buy Aurobindo Pharma: target of Rs 1024: Sharekhan

    Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1024 in its research report dated December 17, 2020.

  • COVID Vaccine: The opportunities for investors - Part I Dec 11, 2020 08:32 AM IST

    COVID Vaccine: The opportunities for investors - Part I

    Vaccine rollout will throw up opportunities not just for the domestic pharmaceutical and healthcare industry but also the logistics value chain, right from vaccine production, delivery, storage and then the actual immunisation

  • Accumulate Aurobindo Pharma; target of Rs 921: Prabhudas Lilladher Nov 18, 2020 01:57 PM IST

    Accumulate Aurobindo Pharma; target of Rs 921: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 921 in its research report dated November 12, 2020.

  • Buy Aurobindo Pharma; target of Rs 1025: ICICI Direct Nov 17, 2020 11:22 AM IST

    Buy Aurobindo Pharma; target of Rs 1025: ICICI Direct

    ICICI Direct is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1025 in its research report dated November 12, 2020.

  • Buy Aurobindo Pharma; target of Rs 980: Motilal Oswal Nov 15, 2020 11:56 AM IST

    Buy Aurobindo Pharma; target of Rs 980: Motilal Oswal

    Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 980 in its research report dated November 12, 2020.

  • Buy Aurobindo Pharma: target of Rs 1024: Sharekhan Nov 15, 2020 11:31 AM IST

    Buy Aurobindo Pharma: target of Rs 1024: Sharekhan

    Sharekhan is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1024 in its research report dated November 12, 2020.

  • Buy Aurobindo Pharma; target of Rs 985: Motilal Oswal Oct 28, 2020 01:19 PM IST

    Buy Aurobindo Pharma; target of Rs 985: Motilal Oswal

    Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 985 in its research report dated October 26, 2020.

  • Buy Aurobindo Pharma; target of Rs 1025: ICICI Direct Oct 27, 2020 02:00 PM IST

    Buy Aurobindo Pharma; target of Rs 1025: ICICI Direct

    ICICI Direct is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1025 in its research report dated October 26, 2020.

  • Buy Aurobindo Pharma; target of Rs 1030: Motilal Oswal Sep 28, 2020 11:22 PM IST

    Buy Aurobindo Pharma; target of Rs 1030: Motilal Oswal

    Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1030 in its research report dated September 27, 2020.

  • Buy Aurobindo Pharma; target of Rs 975: Sharekhan Sep 23, 2020 12:14 PM IST

    Buy Aurobindo Pharma; target of Rs 975: Sharekhan

    Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 975 in its research report dated September 22, 2020.

  • Aurobindo Pharma: Shot in the arm for Covid vaccine development programme Sep 16, 2020 09:40 AM IST

    Aurobindo Pharma: Shot in the arm for Covid vaccine development programme

    Vaccine capacity creation puts Aurobindo in the league of Serum Institute of India and Cadila in the race for a Covid drug

  • Buy Aurobindo Pharma; target of Rs 1027: KR Choksey Aug 19, 2020 11:07 AM IST

    Buy Aurobindo Pharma; target of Rs 1027: KR Choksey

    KR Choksey is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1027 in its research report dated August 17, 2020.

  • Buy Aurobindo Pharma; target of Rs 1000: Emkay Global Financial Aug 17, 2020 05:06 PM IST

    Buy Aurobindo Pharma; target of Rs 1000: Emkay Global Financial

    Emkay Global Financial is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1000 in its research report dated August 13, 2020.

  • Hold Aurobindo Pharma; target of Rs 838: Prabhudas Lilladher Aug 16, 2020 09:08 AM IST

    Hold Aurobindo Pharma; target of Rs 838: Prabhudas Lilladher

    Prabhudas Lilladher recommended Hold rating on Aurobindo Pharma with a target price of Rs 838 in its research report dated August 13, 2020.

  • Hold Aurobindo Pharma; target of Rs 975: Sharekhan Aug 16, 2020 07:21 AM IST

    Hold Aurobindo Pharma; target of Rs 975: Sharekhan

    Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 975 in its research report dated August 13, 2020.

  • Buy Aurobindo Pharma; target of Rs 1055: Motilal Oswal Aug 16, 2020 07:20 AM IST

    Buy Aurobindo Pharma; target of Rs 1055: Motilal Oswal

    Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1055 in its research report dated August 13, 2020.

  • Aurobindo Pharma: Debt reduction lends confidence Aug 14, 2020 12:22 PM IST

    Aurobindo Pharma: Debt reduction lends confidence

    Aurobindo is building capacities for emerging drug delivery systems in the US and could be a key beneficiary of the localisation initiative there

  • Buy Aurobindo Pharma; target of Rs 1100: ICICI Direct Aug 14, 2020 12:22 PM IST

    Buy Aurobindo Pharma; target of Rs 1100: ICICI Direct

    ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated August 13, 2020.

  • Buy Aurobindo Pharma; target of Rs 835: Emkay Global Financial Jun 07, 2020 08:50 PM IST

    Buy Aurobindo Pharma; target of Rs 835: Emkay Global Financial

    Emkay Global Financial is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 835 in its research report dated June 04, 2020.

  • Buy Aurobindo Pharma; target of Rs 880: Motilal Oswal Jun 07, 2020 08:36 PM IST

    Buy Aurobindo Pharma; target of Rs 880: Motilal Oswal

    Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 880 in its research report dated June 04, 2020.

Sections